Use of botulinum toxin type A in management of adult spasticity - A European consensus statement

Journal of Rehabilitation Medicine

Volumn 35, Issue 2, 2003, Pages 98-99

  Ward, Anthony B ^a   Aguilar, Miguel ^b   De Beyl, Zegers ^c   Gedin, Susanne ^d   Kanovsky, Petr ^e   Molteni, Franco ^f   Wissel, Jörg ^g   Yakovleff, Anton ^h  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

^c ERASME HOSPITAL   (Belgium)

^d HELSINGBORG HOSPITAL   (Sweden)

^e MASARYK UNIVERSITY   (Czech Republic)

^f Valduce Rehabilitation Centre   (Italy)

^g Department of Neurology   (Germany)

^h UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; CAREGIVER; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG SYNTHESIS; EUROPE; EVIDENCE BASED MEDICINE; EXERCISE; FAMILY; GOOD CLINICAL PRACTICE; HEALTH INSURANCE; LONG TERM CARE; MUSCLE STRETCHING; NEUROLOGY; NOTE; OCCUPATIONAL THERAPY; PHARMACY; PHYSICIAN; PHYSIOTHERAPY; PRACTICE GUIDELINE; SIDE EFFECT; SPASTICITY; SPLINTING; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXIN TYPE A; CONSENSUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EUROPE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MUSCLE SPASTICITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0037338948     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.1080/16501970306112     Document Type: Note

References (4)

1. Ward AB (Chairman), Working party report on the management of adults with spasticity using botulinum toxin. Byfleet: Radius Healthcare; April 2001.
2. Turner Stokes L, Ward AB. The use of botulinum toxin in the management of adults with spasticity. Clinical Medicine (JRCPL) 2002; 2: 128-130.
3. Guidance for the Use of Botulinum Toxin in the Management of Spasticity in Adults. Royal College of Physicians of London Clinical Effectiveness & Evaluation Unit. Royal College of Physicians: London; July 2002
4. Spasticity Study Group (Brin MF, Chairman). Etiology, evaluation and management of spasticity, and the role of botulinum toxin type A. Muscle & Nerve 1997 (Suppl 6); S1-S256.